Pay in 4 interest-free payments of $87.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Pay in 4 interest-free payments of $87.14 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Tratamiento de enfermedades autoinmunes graves
KADCYLA® 160 mg es un medicamento de uso intravenoso que contiene Trastuzumab Emtansina (T-DM1)
PRINCIPIO ACTIVO: SALMETEROL - FLUTICASONA
DOSIS: 800 MG
TREMECOX 300/15 MG TAB 20 AMLODIPINO Tratamiento de enfermedades autoinmunes gravesPRINCIPIO ACTIVO: GABAPENTINA, MELOXICAM
US$ 3846.50
US$ 3496.50
US$ 375.50
US$ 2495.00
US$ 1495.00
US$ 2396.00
US$ 4995.00
US$ 381.50